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Abstract
Objective: The objective of this study was to evaluate the effects of intraoperative epidural anesthesia 
combined with balanced general anesthesia on intraoperative hemodynamics and fl uid requirement, and 
on postoperative patient outcome. 
Design: The study design was a retrospective data analysis of patients undergoing open hepatectomy 
at a single tertiary care center from May, 2013 to June, 2016. Patients undergoing hepatectomies were 
separated into two groups: patients not receiving epidural local anesthetic intraoperatively (either no 
epidural or epidural catheter not used intraoperatively) were designated the control group and patients 
receiving epidural local anesthetic intraoperatively (bolus and/or continuously). Patients were excluded if 
they underwent laparoscopic or non-elective procedures. 
Results: 103 patients were included in the data analysis: Control n=14, Epidural = 89 patients. There 
were no major differences in demographics between groups. Epidural patients did not have higher 
requirements in intraoperative intravenous fl uid administration, blood loss, or vasopressor use compared 
to control patients. Patients who received epidurals required less intravenous opioids with better post-
operative pain scores initially and also on post-operative day 2. There were no differences in length of time 
to ambulation, or post-operative acute kidney injury amongst groups. 
Conclusions: This study shows that patients undergoing hepatectomies using combined epidural 
and general anesthesia: 1) have no increased requirement for intraoperative crystalloid, colloid, or blood 
component therapy, 2) require lower total intravenous opioid dose, and 3) subjectively report better 
pain control. Therefore, intraoperative epidural anesthesia combined with general anesthesia may be 
advantageous for ERAS protocol based oncological procedures.
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Introduction
Enhanced Recovery after Surgery (ERAS) protocols are becoming more frequently 
used for several surgical procedures after they were ϐirst described by colorectal 
surgeons in the 1990’s. The goal of ERAS protocols is to facilitate the early return of 
patients to normal physiology by minimizing perioperative stressors [1]. In the ϐield 
of liver surgery randomized clinical trials have proven that ERAS protocols lead to 
reduced post-operative complications [1]. 
Epidural anesthesia has been successfully implemented as part of a multimodal 
approach to pain control in patients undergoing ERAS protocols. Epidural usages 
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can provide high quality analgesia while also leading to decreased cardiopulmonary 
complications, reduced ileus and early mobilization of patients following liver resection 
[1-3]. However epidural placement and usage is not without complications. This includes 
sympathectomy induced hypotension, spinal headache, epidural hematomas, epidural 
abscess or spinal cord injury [3]. Post-operative coagulopathy is expected after liver 
surgery due a combination of the extent of liver resection, consumptive coagulopathy, 
and blood loss. The degree of post-operative coagulopathy can be related to preoperative 
liver synthetic function. Thus, this transient post-operative coagulopathy is typically 
maximally deranged on postoperative days one and two and typically resolves on 
its own within ϐive to seven days [3,4]. Therefore, there may be some hesitation by 
anesthesia providers to use epidural analgesia perioperatively for this procedure. While 
the coagulopathy may pose an increased risk of epidural hematoma formation patients 
undergoing hepatectomy and should be monitored prior to epidural catheter removal, it 
does not prohibit the placement and usage of epidural analgesia [3,4]. 
Surgical resection is mainstay for a majority of cancer treatment even though 
excision of the primary tumor can result in further dissemination and growth. Stress 
from both a surgical and anesthetic point of view has been shown to suppress the 
immune system [5]. Pain is an obvious inducer of the stress response thus medication 
to reduce pain and inϐlammation such as opioids and non-steroidal anti-inϐlammatories 
(NSAIDs) can decrease metastatic potential in animal models and humans. Regional 
anesthesia can dramatically reduce many of these stress response effects of surgery 
and anesthesia. Studies have shown that patients undergoing abdominal surgery with 
epidural analgesia had higher numbers of lymphocytes, T-helper cells, preserved 
interferon-γ concentrations and a beneϐicial Helper T cell ratio [5]. 
Thus, the practice of using epidural analgesia to decrease pain and inϐlammation 
as well as opioid sparing with local anesthesia may play an important role on immune 
function and cancer recurrence. However, aggressive use of epidural anesthesia in 
combination with general anesthesia during hepatectomy may have signiϐicant impact 
on hemodynamics and intravenous ϐluid requirements. 
The primary aim of this study was to investigate if the intraoperative use of 
epidural anesthesia and analgesia combined with general anesthesia is associated 
with increased use of vasoactive medications or need for more intravenous ϐluid 
administration. In addition, the study explored if the epidural use was related to 
differences in postoperative analgesia or opioid consumption. We hypothesized that 
epidural anesthesia can be safely used intraoperatively during open hepatectomy and 
does not interfere with the goals of ERAS protocols for this procedure. 
Material and Methods
After approval from the University of Kentucky Institutional Review Board, a 
retrospective data analysis was performed on patients undergoing elective open 
hepatectomy from May, 2013 to June, 2016. The patient collective was separated into 
two groups: patients not receiving epidural local anesthetic intraoperatively (either 
no epidural or epidural catheter not used intraoperatively) were designated the 
control group [C] and patients receiving epidural local anesthetic intraoperatively [E]. 
Inclusion criteria into the study was deϐined as patients undergoing open procedures 
for removal of either primary liver tumors or with metastases to liver. After excluding 
patients that underwent laparoscopic procedures, patients with history of liver 
transplantation or non-elective procedures, we enrolled fourteen control patients and 
eighty-nine epidural patients. We did not take into account if the patient had cirrhosis 
or make a distinction between a major or minor hepatectomy in this study.
Due to the small number of control patients compared to those with an epidural, we 
identiϐied a subgroup of patients in the Epidural group, in which epidural anesthesia 
was provided as continuous infusion of local anesthetic (lidocaine 1% or bupivacaine 
0.125%) intraoperatively as adjunct to general anesthesia (E gtt, n=23). To further 
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quantify the association of epidural use and vasopressor requirements, we performed 
a subgroup analysis (Control [C] n=14, Epidural bolus use [E bolus, n=66], and 
Epidural continuous infusion [E gtt, n=23]. The main difference between E bolus and 
E gtt was that the majority of patients in the E bolus group did not receive epidural 
local anesthetics until the ϐinal stage of the surgical procedure. The frequency of 
intraoperative vasoconstrictive medication administration for all groups was recorded. 
Data collection was performed in a blinded fashion by a clinical support staff 
member that was not involved in the analysis of the data before patients were 
separated in respective groups. Intraoperative data were collected and analyzed for 
opioid use with all opioids converted to fentanyl equivalents via the Global RPh opioid 
equivalence calculator [6] and tallied together in Microsoft Excel to determine total 
dose, frequency of hypotension deϐined as a mean arterial pressure (MAP) less than 
60mmHg for >10min duration post incision. Vasopressor therapy was deϐined as either 
no usage, low dose: less than 500 micrograms (mcg) Phenylephrine, 25 milligrams 
(mg) ephedrine, or 2 units of vasopressin accumulatively for the procedure, or high 
dose: any vasopressor infusion, any bolus of epinephrine, any combination of drugs 
where one drug is a greater than any low parameter. 
To investigate the intraoperative implications of continuous epidural anesthesia for 
intraoperative management during hepatectomy, we reviewed the anesthesia records 
of patient without epidural use [C] and continuous epidural anesthesia [EPI gtt] and 
calculated the intraoperative doses of vasoconstrictive medications. 
Average total ϐluid administration including blood transfusion, and estimated blood 
loss were other intraoperative factors compared between the control and epidural 
groups. We also recorded the total amount of opioid for the case after converting all 
drugs and routes to intravenous fentanyl equivalents.
Post-operative data were analyzed for pain scores immediately post op, twenty-
four and forty-eight hours postoperatively, length of stay, time to ambulation and rate 
of acute kidney injury. Data are presented as mean ± standard deviation. Statistical 
analysis was performed using a paired T-test and Fisher’s Exact test. Statistical 
signiϐicance was assumed if P value was less than 0.05. 
Results
Eighty-nine of the one hundred and three patients met our inclusion criteria and 
there were no signiϐicant demographic differences between the two groups: age (p = 
0.35), American Society of Anesthesia Class (p = 0.22), male to female ratio (p = 0.09) 
and operating room duration (p = 0.25) (Table 1). Intraoperative epidural use was not 
associated with differences in estimated blood loss (p = 0.33), packed red blood cell 
transfusion (p = 0.27), total ϐluid administration (crystalloid and colloids) (p = 0.5), 
total intravenous crystalloid ϐluid (p = 0.45), and intravenous albumin administration 
(p = 0.98). Measured urine output for the case was also compared between the two 
groups and was found to have no signiϐicant difference as well (p = 0.51) (Table 2). 
There were no differences in the requirements and extent of vasopressor therapy 
between the two cohorts. There was no signiϐicant difference in the no vasopressor 
requirement (E: 33 out of 89 patients, C: 8 out of 14 patients; p = 0.27), low vasopressor 
requirements (E: 23 out of 89 patients, C: 1 out of 14 patients; p = 0.31), and high 
vasopressor requirement (E: 33 out of 89 patients, C: 5 out of 14 patients; p = 0.62) 
factions between the control and epidural cohorts (Figure 1). 
Table 1: Demographics of the study population by method of pain control. Data presented as mean ± SD.
Epidural Control p-value
N 89 14
Age (years) 54.2 ± 12.7 50.7 ± 10.1 0.35
ASA class 2.9 ± 0.5 3.0 ± 0.4 0.22
M:F ratio 42:47 10:4 0.09
OR duration (min) 269 ± 91 286 ± 113 0.25
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To obtained more detailed information about vasopressor use and association 
with intraoperative epidural anesthesia, we identiϐied a subgroup of patients in the 
Epidural group, in which epidural anesthesia was provided as continuous infusion of 
local anesthetic (lidocaine 1% or bupivacaine 0.125%) intraoperatively as adjunct 
to general anesthesia (E gtt, n=23). The frequency of intraoperative vasoconstrictive 
medication administration is shown in table 3. The frequency of vasoconstrictive 
medications was not signiϐicantly different between Control group and epidural 
bolus use. There was no difference in low vasopressor requirements between Control 
patients and patients receiving continuous epidural anesthesia intraoperatively. 
For further analysis of intraoperative vasoconstrictive medication administration, 
we calculated the intraoperative doses of vasoconstrictive medications given to 
patients in the Control group and to patients with continuous epidural anesthesia 
(Table 4). The most commonly given agent was phenylephrine. The phenylephrine 
dose was not different between the groups. The other agents (ephedrine, vasopressin 
and norepinephrine) were given less frequently and less consistently, most likely 
representing the preferences of the anesthesia provider. While the data indicated a 
signiϐicantly larger dose of ephedrine in patients with continuous epidural anesthesia, 
the other, more potent vasoactive medications (Vasopressin and Norepinephrine) 
were used in both groups in similar concentrations. 
In addition to vasopressor use, the subanalysis did not show any differences in 
intravenous ϐluid administration between the control group and patients receiving 
continuous intraoperative epidural anesthesia. In average, patient in the control group 
received 2757 ± 2436ml intravenous ϐluids (crystalloid 2436 ± 2169ml, albumin 5% 
Table 2: Effects of epidural usage on intraoperative fl uid requirements and urine output compared to control. Data 
presented as mean ± SD.
Epidural Control p-value
N 89 14
EBL (mL) 292 ± 307 455 ± 585 0.33
Total Fluids (mL) 2301± 1236 2757 ± 2436 0.5
IVF Crystalloid (mL) 1975 ± 1020 2436 ± 2166 0.45
IVF Albumin 5% (mL) 325 ± 400 321 ± 504 0.98
PRBC transfusion (units) 0.03 ± 0.3 0.5 ± 1.3 0.27
UOP (mL) 208 ± 172 356 ± 418 0.51
Figure 1: Effects of epidural usage on intraoperative vasopressor frequency and magnitude. 
The frequency of vasopressor use was compared in the following groups: patients receiving epidural anesthesia 
combined with general anesthesia intraoperatively [Epidural, n=89], were compared to patients without epidural 
anesthesia or not used intraoperatively [Control, n=14]. 
Vasopressors were quantifi ed as no usage, Low = < 500mcg Phenylephrine, < 25mg ephedrine, < 2 units of 
vasopressin for the case. High = any vasopressor infusion, any bolus of epinephrine or any combination of drugs 
where one drug is a greater than any low parameter. Data presented as fraction from total.
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Figure 2: Comparison of the effect of epidural usage and intraoperative opioid requirements in IV bolus form and 
case total opioids. All opioids have been converted in to intravenous fentanyl equivalents [6]. 
Data presented as mean ± SEM. * = p < 0.05.
Table 3: Frequency of intraoperative vasoconstrictive medication administration. 
Control: no epidural anesthesia, E bolus: bolus epidural local anesthetics, E gtt: continuous intraoperative epidural local 
anesthetic infusion.
Statistical analysis with Fisher exact test (p=values), * p<0.05.
Control E bolus E gtt
N 14 66 23
P value
C vs E bolus
P value
C vs E gtt
No vasopressor use 8 28 5 0.14 0.03
Low vasopressor use 1 16 7 0.24 0.07
High vasopressor use 5 22 11
0.76
high vs low
0.38
0.14
high vs low
0.62
Table 4: IntraoperativeVasopressor doses for selected subgroups.
Control: no epidural anesthesia, E gtt: continuous intraoperative epidural local anesthetic infusion.
Data are presented as mean ± SD. Statistical analysis with paired t-test * p<0.05.
Control E gtt P value
N 14 23
Phenylephrine [mcg] 1064.1 ± 3681.7 635.6 ± 1230.4 0.61
Ephedrine [mg] 1.43 ± 5.35 12.83 ± 19.47* 0.04
Vasopressin [Units] 1.37 ± 3.08 1.05 ± 2.91 0.75
Norepinephrine [mcg] 29.57 ± 110.65 4.66 ± 22.36 0.30
321 ± 504ml). The average for patient with intraoperative continuous epidural local 
anesthesia infusion [E gtt] was 2244 ± 1330ml (crystalloid 1859 ± 1077ml, albumin 
5% 385 ± 395ml). 
When comparing opioid requirements between the control and epidural group, 
the epidural cohort required signiϐicantly less intravenously bolused opioids 286 ± 
251mcg in the epidural group versus 629 ± 568 mcg in the control group (p = 0.04). 
However, when comparing the total dose of opioids for the case 426 ± 251 mcg in the 
epidural group versus 629 ± 568 mcg in the control group this was not signiϐicantly 
different (p = 0.21) (Figure 2). 
Post operatively, pain scores were assessed via the Visual Analog Scale (VAS) 
initially after surgery, post-operative day one (24hrs postop) and post operatively day 
two (48hrs postop). There was a signiϐicant difference in VAS pain scores at the initial 
assessment 5.4 ± 3.5 in the epidural cohort versus 8.25 ± 2.0 in the control (p < 0.01). 
This was shown as well on post-operative day two 4.2 ± 2.8 in the epidural cohort and 
6.8 ± 1.5 in the control cohort (p < 0.01). However, pain scores on postoperative day 
one were not signiϐicantly different between the two cohorts (p = 0.06) (Figure 3). The 
rate of acute kidney injury (p = 0.64), time to ambulation (p = 0.11), time to eating (p = 
0.25), time to ϐirst bowel movement (p = 0.25), and time to discharge (p = 0.46) were 
not different between the two cohorts (Table 5). 
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The selection of pain control method was not standardized for the patient population 
and was determined by the surgeon and attending anesthesiologist. Postoperative pain 
control for rescue was again not standardized as this was at the discretion of the acute 
pain attending anesthesiologist. Rescue maneuvers that occurred would have included 
titration of the epidural infusion with continued patient-controlled boluses, addition 
of intravenous patient-controlled analgesia after removal of the opioid component in 
the epidural infusion, removal of the epidural catheter if deemed non-functional and 
utilization of intravenous or oral opioid medications. In the control group post-operative 
analgesia outside of the post-operative care unit was at the discretion of the attending 
surgical oncologist. There was no reported epidural hematoma or abscess formation 
after epidural placement or removal, however there is no data on any delays in catheter 
removal secondary to coagulopathy. 
Discussion
Epidural usage during abdominal surgeries provides excellent analgesia with reduced 
cardiopulmonary complications, duration of ileus and opioid requirements however, 
there is concern over complications associated with their usage and placement [3,7]. 
Liver surgery itself places patients at an increased risk of post-operative coagulopathy 
and development of epidural hematoma following catheter removal [3,4]. Other 
complications of intraoperative epidural usage in ERAS patients are sympathectomy 
induced hypotension with concomitant additional ϐluid requirements and possibly red 
cell transfusion [1-3]. 
Our study found that the intraoperative use of epidural anesthesia and analgesia with 
local anesthetics and opioids in addition to general anesthesia during hepatectomy is 
not associated with an increased vasopressor use or intravenous ϐluid administration. 
The study conϐirmed that intraoperative epidural use is safe and that the provided 
analgesia may be superior to intravenous opioid based analgesia, and may offer 
additional opioid-sparing advantages for patients undergoing oncological resections. 
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Figure 3: Effects of epidural usage on VAS scores on the initial post-operative assessment, and maximum pain 
scores on post-operative day 1 and 2. Data presented as mean ± SEM. * = p < 0.05
Table 5: Comparison of post-operative outcomes in patients that received epidural analgesia versus control. Data 
presented as mean ± SD.
Epidural Control p-value
N 89 14
AKI (percent of patients) 8.9% 7.1% 0.64
Time to ambulation (days) 2.1 ± 1.3 2.9 ± 1.6 0.11
Time to eating (days) 3.6 ± 1.8 4.9 ± 4.0 0.25
Time to return of bowel function (hours) 87 ± 24 97 ± 35 0.21
Time to discharge (days) 6.9 ± 3.3 7.7 ± 3.6 0.46
Effects of intraoperative epidural anesthesia during hepatectomy on intraoperative and post-operative patient outcomes
Published: November 13, 2018 029
Epidural induced sympathectomy and concomitant hypotension can lead to 
increased ϐluid and vasopressor requirements as a response to the relative hypovolemia. 
This is a concern in patients undergoing major abdominal surgery with ERAS protocols 
[1-3]. Our study showed no statistically signiϐicant increase in ϐluid requirements, blood 
product transfusion or vasopressor usage. Speciϐically, our study documented that 
the continuous epidural local anesthesia infusions as an adjunct to balanced general 
anesthesia did not increase intravenous ϐluid administration or changed vasopressor 
requirements, therefore supporting the goals of the ERAS approach. These results 
are a favorable hemodynamic proϐile with epidural usage in comparison to the recent 
literature. Allen et al. [2], showed no signiϐicant difference in ϐluid requirements 
between their cohort comparing epidural and IVPCA patients undergoing liver 
resection. However, Siniscalchi et al. [4], found that epidural anesthesia increased 
the use of intravenous colloid administration. However, they did not ϐind a difference 
in crystalloid or red cell transfusion. Recorded urine output in this study showed no 
signiϐicant difference between epidural and control patients, this is similar in result 
to the Siniscalchi et al. [1]. To our knowledge, this is the ϐirst study documenting that 
epidural anesthesia in combination with general anesthesia is not associated with 
an increased use in vasoconstrictive or inotrope medications during hepatectomy to 
maintain normotension. While Siniscalchi et al. [1] reported an association of epidural 
anesthesia with lower MAP post liver resection and at the end of surgery, the authors 
did not report intraoperative treatment and signiϐicance of the hypotension. 
This study data indicates that epidural usage intraoperatively leads to decreased 
bolus IV opioids, however total dose of opioid was not statistically signiϐicant. Usage 
of epidural catheters with local anesthetic and opioid may typically results in opioid 
sparing effects. This may be beneϐicial due to studies showing that opioids themselves 
can result in tumor progression via endothelial cell proliferation and angiogenesis5. 
Non-small cell lung carcinomas for example have been shown to express the mu-
opioid receptor at ϐive to ten-fold higher levels than normal cells. Morphine has been 
the most studied opioid in this context and has been shown to stimulate endothelial 
cell proliferation, inhibition endothelial apoptosis resulting in angiogenesis and tumor 
progression in rat models. However, opioids themselves assist in blocking the stress 
response which may lead to a favorable immunologic proϐile in the patient possibly 
leading to decreased metastasis. This is due in part to pro-inϐlammatory cytokines 
decreasing T-cell, B-cell and natural killer (NK) cell function for days following a 
surgical insult. NK cells play an important role in tumor biology since their activity 
can be correlated to patient’s susceptibility to multiple types of cancers. Studies 
have shown that decreased NK cell activity from stress induced cytokines results in 
increased metastasis and when those stress cytokines are blocked we see the reverse 
effect5. This makes a case for further study into long term cancer recurrence in patients 
undergoing hepatectomies with opioid sparing techniques. However, the data about 
immunomodulation has been only shown in rat models and no long-term translation 
studies in humans have been conducted thus far. 
In regards to routes of administration when given systemically opioids act on 
all corresponding receptors throughout the body. Studies have shown that there is 
synergy between spinal and systemic administration where small doses of spinal 
morphine signiϐicantly potentiated the activity of systemic morphine [8]. In clinical 
practice, epidural administration of opioids leads to higher concentrations of the drug 
at the spinal level secondary to their diffusion into the cerebrospinal ϐluid. Also the 
epidurally administered opioid is absorbed into the systemic circulation via the highly 
vascular Batson’s venous plexus [9]. This could explain the decreased requirements 
for bolus IV opioid in our epidural group. 
Post-operative outcomes were also assessed and patients that received epidurals 
had superior pain control immediately post-op as well as at 48 hours based off VAS 
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scores. It was also noted that when comparing the two groups there was no difference 
in the rate of AKI post op as well. However, other post-operative outcomes such as 
length of stay and time to eating, return of bowel function, ambulation did not show 
any signiϐicant difference. This is an agreement with the Allen et al. [2] study who also 
was unable to show differences in length of stay or time to eating and Siniscalchi et al. 
[1], who compared creatinine at post-op days 1, 3 and 7.
Potential limitations of this study are its retrospective nature and the possible addition 
of selection and/or information biases. We were reliant upon the documentation in the 
medical record as accurate and precise with proper standardization. However, there is 
the opportunity for the variable to either be missing, delayed or incomplete. There was 
also no standardized anesthetic plan for patients undergoing elective hepatectomies and 
thus some patients received other medications both preoperative and intraoperatively 
which may have an effect on the results of this study. The patient cohorts were at a single 
university hospital and thus unable to compare patients undergoing the same procedure in 
other areas of the country. We also are unable to evaluate the long-term impact on patient 
morbidity and mortality to evaluate for long term outcomes of opioid sparing techniques. 
This study shows that patients undergoing hepatectomies using combined epidural and 
general anesthesia had no increased intraoperative requirements for intravenous ϐluid and 
vasopressor usage and required a lower total intravenous opioid dose perioperatively for 
adequate pain control. When comparing postoperative outcomes, patients with epidurals 
had better pain control without a difference in post-operative complications. Although 
we did not ϐind differences in length of stay, time to ambulation, or time to tolerating oral 
intake, future studies are needed to explore any advantages of opioid sparing anesthesia 
techniques for patients undergoing hepatectomy. Thus, with the advent of ERAS protocols 
and fast track liver surgery combined epidural and general anesthesia is safe and possibly 
more beneϐicial outcomes given the decreased IV opioid requirements.
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